• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.

作者信息

Walczak Pierre, Choquet Sylvain, Dantal Jacques, Boutboul David, Suarez Felipe, Baron Marine, Morel Veronique, Cluzeau Thomas, Touati Mohamed, Elias Michelle, Bachy Emmanuel, Nicolas-Virelizier Emmanuelle, Houot Roch, Venton Geoffroy, Jacquet Caroline, Moles-Moreau Marie-Pierre, Jardin Fabrice, Durot Eric, Balegroune Noureddine, Ecotiere Laure, Guieze Romain, Kamar Nassim, Ysebaert Loic, Couzi Lionel, Gonzalez Hugo, Roulin Louise, Ou Kevin, Caillard Sophie, Zimmermann Heiner, Trappe Ralf Ulrich, Roos-Weil Damien

机构信息

Sorbonne Universite, Service d'Hematologie Clinique, Hopital Pitie-Salpetriere, APHP, Paris.

Institut de Transplantation Urologie Nephrologie (ITUN), Service de Nephrologie et Immunologie clinique, CHU Nantes, Nantes.

出版信息

Haematologica. 2023 Oct 1;108(10):2814-2819. doi: 10.3324/haematol.2022.282297.

DOI:10.3324/haematol.2022.282297
PMID:36891749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10543171/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafb/10543171/dcafaf59309d/1082814.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafb/10543171/dcafaf59309d/1082814.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bafb/10543171/dcafaf59309d/1082814.fig1.jpg

相似文献

1
Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients.移植后伯基特淋巴瘤：55例患者的回顾性研究
Haematologica. 2023 Oct 1;108(10):2814-2819. doi: 10.3324/haematol.2022.282297.
2
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.成人实体器官移植受者中的移植后 Burkitt 淋巴瘤：利妥昔单抗（R）序贯免疫化疗，随后是环磷酰胺、多柔比星、长春新碱和泼尼松（CHOP）或 R-CHOP，在对 8 例患者的分析中是安全有效的。
Cancer. 2012 Oct 1;118(19):4715-24. doi: 10.1002/cncr.27482. Epub 2012 Mar 5.
3
Endemic Burkitt lymphoma of maxillofacial region: results of induction treatment with cyclophosphamide plus methotrexate in West Africa.面颌部地方性伯基特淋巴瘤：在西非用环磷酰胺加甲氨蝶呤诱导治疗的结果。
Pediatr Blood Cancer. 2011 Jul 1;56(7):1068-70. doi: 10.1002/pbc.23058. Epub 2011 Feb 22.
4
Dose-adjusted EPOCH-R for Burkitt lymphoma.用于伯基特淋巴瘤的剂量调整型EPOCH-R方案
Clin Adv Hematol Oncol. 2014 Nov;12(11):777-9.
5
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.艾滋病相关伯基特淋巴瘤的临床结果：日本多机构回顾性调查。
Jpn J Clin Oncol. 2014 Apr;44(4):318-23. doi: 10.1093/jjco/hyu012. Epub 2014 Feb 20.
6
New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.弥漫性大 B 细胞淋巴瘤和伯基特淋巴瘤分子亚型生物学的新见解。
Best Pract Res Clin Haematol. 2012 Mar;25(1):3-12. doi: 10.1016/j.beha.2012.01.003. Epub 2012 Feb 8.
7
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.成人散发性伯基特淋巴瘤的治疗：四种治疗方案的回顾性比较
Ann Hematol. 2018 Feb;97(2):255-266. doi: 10.1007/s00277-017-3167-7. Epub 2017 Dec 6.
8
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.利妥昔单抗联合化疗治疗中枢神经系统和/或骨髓阳性的儿童及青少年伯基特淋巴瘤/白血病：儿童肿瘤学组报告
Br J Haematol. 2014 Nov;167(3):394-401. doi: 10.1111/bjh.13040. Epub 2014 Jul 26.
9
Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.对一名具有伯基特样形态的原发性皮肤弥漫性大B细胞淋巴瘤患者进行强化化疗。
Intern Med. 2009;48(6):475-8. doi: 10.2169/internalmedicine.48.1791. Epub 2009 Mar 16.
10
Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature.以甲状腺肿块为表现的伯基特淋巴瘤：7例临床病理研究及文献复习
Hum Pathol. 2016 Oct;56:101-8. doi: 10.1016/j.humpath.2016.05.018. Epub 2016 May 30.

本文引用的文献

1
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.实体器官移植后伯基特淋巴瘤：儿科 PTLD 协作中的治疗和结局。
Br J Haematol. 2023 Feb;200(3):297-305. doi: 10.1111/bjh.18498. Epub 2022 Dec 1.
2
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.改良风险分层序贯治疗（皮下利妥昔单抗联合或不联合化疗）在实体器官移植后 B 细胞移植后淋巴增殖性疾病（PTLD）中的应用：前瞻性多中心 II 期 PTLD-2 试验。
Leukemia. 2022 Oct;36(10):2468-2478. doi: 10.1038/s41375-022-01667-1. Epub 2022 Aug 16.
3
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版：淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
4
Front-line management of post-transplantation lymphoproliferative disorder in adult solid organ recipient patients - A British Society for Haematology Guideline.成人实体器官移植受者移植后淋巴细胞增生性疾病的一线管理——英国血液学学会指南
Br J Haematol. 2021 May;193(4):727-740. doi: 10.1111/bjh.17421. Epub 2021 Apr 20.
5
Burkitt Lymphoma International Prognostic Index.Burkitt 淋巴瘤国际预后指数。
J Clin Oncol. 2021 Apr 1;39(10):1129-1138. doi: 10.1200/JCO.20.03288. Epub 2021 Jan 27.
6
Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series.移植后单相伯基特淋巴瘤：多中心系列的临床特征和结局。
Ann Hematol. 2018 Dec;97(12):2417-2424. doi: 10.1007/s00277-018-3473-8. Epub 2018 Aug 16.
7
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).国际淋巴瘤工作组共识反应评估标准（RECIL 2017）
Ann Oncol. 2017 Jul 1;28(7):1436-1447. doi: 10.1093/annonc/mdx097.
8
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.利妥昔单抗诱导反应是 B 细胞移植后淋巴组织增生性疾病的预测标志物，并允许在一项国际性、前瞻性、多中心 II 期试验中成功分层为利妥昔单抗或 R-CHOP 巩固治疗。
J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19.
9
Post-transplant lymphoproliferative disorders.移植后淋巴组织增生性疾病。
Nat Rev Dis Primers. 2016 Jan 28;2:15088. doi: 10.1038/nrdp.2015.88.
10
How I treat posttransplant lymphoproliferative disorders.我如何治疗移植后淋巴增殖性疾病。
Blood. 2015 Nov 12;126(20):2274-83. doi: 10.1182/blood-2015-05-615872. Epub 2015 Sep 17.